Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07403500
Recruiting
Evaluation of the Short-term Effectiveness of Spinal Manipulation to Treat Acute and Subacute Low Back Pain.
Not applicable · France · 1 site
Registry update: 23 Oct 2026
NCT07570758
Recruiting
A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.
Phase 2 · United States · 3 sites
Registry update: 22 Jun 2026
NCT07584135
Recruiting
JS107 in Combination With Toripalimab and Chemotherapy for the Treatment of CLDN18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma
Phase 3 · China · 1 site
Registry update: 29 Jun 2026
NCT07524101
Recruiting
Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
Not applicable · South Korea · 1 site
Registry update: 16 Jun 2026
NCT07470879
Recruiting
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
Phase 2 · Australia, Canada, Germany, Finland, France, United Kingdom, Israel, Italy, Japan, Poland, Slovakia, United States · 53 sites
Registry update: 26 Oct 2026
NCT07641309
Recruiting
Measurements Before and After Participation in a Health Intervention Programme in Halsnaes Municipality
Not applicable · Denmark · 1 site
Registry update: 12 Jun 2026
NCT07418827
Recruiting
Determinants and Consequences of the Transition to Adulthood for Adolescents With Severe Haemophilia: TRANSHEMO 2, an Ancillary Study to the TRANSHEMO Project
Not applicable · France · 25 sites
Registry update: 8 Oct 2026
NCT07607964
Recruiting
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
Phase 1 · Japan, United States · 15 sites
Registry update: 20 Oct 2026
NCT07419841
Recruiting
A Phase 1 Study of the Safety and Tolerability of CTX-10726
Phase 1 · United States · 8 sites
Registry update: 23 Oct 2026
NCT07744529
Recruiting
Amivantamab Combined With Intrathecal Pemetrexed for LM From EGFR-Mutated Lung Adenocarcinoma
Phase 1/2 · China · 1 site
Registry update: 4 Aug 2026
NCT07444632
Recruiting
Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
Phase 1 · United States · 1 site
Registry update: 8 Sept 2026
2025-521875-30-00
Recruiting
Administration of Gilteritinib to eliminate MRD in patients with AML and FLT3-ITD mutation.
Phase 2 · Greece · 4 sites
Registry update: 12 Oct 2026
NCT07604571
Recruiting
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
Phase 1 · Canada, Spain, France, Italy, Japan, South Korea, Netherlands, Singapore, United States · 12 sites
Registry update: 3 Nov 2026
NCT07599813
Recruiting
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Phase 2 · Bulgaria, Canada, Czechia, Germany, Spain, Hungary, Poland, United States · 85 sites
Registry update: 28 Aug 2026
NCT07609914
Recruiting
A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
Phase 4 · Israel, United States · 24 sites
Registry update: 14 Oct 2026
NCT07220798
Recruiting
Improving Self-Care of Caregivers of Adults in Homecare With Heart Failure and Cognitive Impairment
Not applicable · United States · 1 site
Registry update: 12 Aug 2026
NCT07061951
Recruiting
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
Phase 2 · United States · 9 sites
Registry update: 6 Oct 2026
NCT07570719
Recruiting
Community-based Screening for Alzheimer's Disease
Not applicable · China · 4 sites
Registry update: 6 Nov 2026
NCT07644325
Recruiting
Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior Carpal Ligament Biopsy
Not applicable · France · 1 site
Registry update: 12 Jun 2026
2025-522001-38-00
Recruiting
A Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease
Phase 2 · Belgium, Bulgaria, Czechia, Germany, Croatia, Italy, Poland, Slovakia · 40 sites
Registry update: 20 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.